1.1.................... moves to amend H.F. No. 600, the eighth engrossment, as follows:
1.2Delete everything after the enacting clause and insert:

1.3    "Section 1. Minnesota Statutes 2020, section 152.25, subdivision 1, is amended to read:
1.4    Subdivision 1. Medical cannabis manufacturer registration. (a) The commissioner
1.5shall register two in-state manufacturers for the production of all medical cannabis within
1.6the state. A registration agreement between the commissioner and a manufacturer is
1.7nontransferable. The commissioner shall register new manufacturers or reregister the existing
1.8manufacturers by December 1 renew existing manufacturer registrations every two years,
1.9using the factors described in this subdivision paragraph (c), and shall accept applications
1.10for new manufacturer registrations at any time. The commissioner shall accept applications
1.11after December 1, 2014, if one of the manufacturers registered before December 1, 2014,
1.12ceases to be registered as a manufacturer. The commissioner's determination that no
1.13manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial
1.14review in Ramsey County District Court. The commissioner may register any manufacturer
1.15that is able to satisfy the factors in paragraph (c) according to standards established by the
1.16commissioner. Data submitted during the application process are private data on individuals
1.17or nonpublic data as defined in section 13.02 until the manufacturer is registered under this
1.18section. Data on a manufacturer that is registered are public data, unless the data are trade
1.19secret or security information under section 13.37.
1.20(b) As a condition for registration, a manufacturer must agree to:
1.21(1) begin supplying medical cannabis to patients by July 1, 2015; and
1.22(2) comply with all requirements under sections 152.22 to 152.37.
1.23(c) The commissioner shall consider the following factors when determining which
1.24manufacturer to register whether to register a manufacturer or renew a registration:
2.1(1) the technical expertise of the manufacturer in cultivating medical cannabis and
2.2converting the medical cannabis into an acceptable delivery method under section 152.22,
2.3subdivision 6;
2.4(2) the qualifications of the manufacturer's employees;
2.5(3) the long-term financial stability of the manufacturer;
2.6(4) the ability to provide appropriate security measures on the premises of the
2.7manufacturer;
2.8(5) whether the manufacturer has demonstrated an ability to meet the medical cannabis
2.9production needs required by sections 152.22 to 152.37; and
2.10(6) the manufacturer's projection and ongoing assessment of fees on patients with a
2.11qualifying medical condition.
2.12(d) If an officer, director, or controlling person of the manufacturer pleads or is found
2.13guilty of intentionally diverting medical cannabis to a person other than allowed by law
2.14under section 152.33, subdivision 1, the commissioner may decide not to renew the
2.15registration of the manufacturer, provided the violation occurred while the person was an
2.16officer, director, or controlling person of the manufacturer.
2.17(e) The commissioner shall require each medical cannabis manufacturer to contract with
2.18an independent laboratory to test medical cannabis produced by the manufacturer. The
2.19commissioner shall approve the laboratory chosen by each manufacturer and require that
2.20the laboratory report testing results to the manufacturer in a manner determined by the
2.21commissioner.

2.22    Sec. 2. Minnesota Statutes 2020, section 152.29, subdivision 1, is amended to read:
2.23    Subdivision 1. Manufacturer; requirements. (a) A manufacturer may operate throughout
2.24the state. A manufacturer may operate eight distribution facilities, which may include the
2.25manufacturer's single location for cultivation, harvesting, manufacturing, packaging, and
2.26processing but is not required to include that location. The commissioner shall designate
2.27the geographical service areas to be served by each manufacturer based on geographical
2.28need throughout the state to improve patient access. A manufacturer shall not have more
2.29than two distribution facilities in each geographical service area assigned to the manufacturer
2.30by the commissioner. A manufacturer shall operate only one location where all cultivation,
2.31harvesting, manufacturing, packaging, and processing of medical cannabis shall be conducted.
2.32This location may be one of the manufacturer's distribution facility sites. The additional
2.33distribution facilities may dispense medical cannabis and medical cannabis products but
3.1may not contain any medical cannabis in a form other than those forms allowed under
3.2section 152.22, subdivision 6, and the manufacturer shall not conduct any cultivation,
3.3harvesting, manufacturing, packaging, or processing at the other distribution facility sites.
3.4Any distribution facility operated by the manufacturer is subject to all of the requirements
3.5applying to the manufacturer under sections 152.22 to 152.37, including, but not limited
3.6to, security and distribution requirements.
3.7(b) A manufacturer may acquire hemp grown in this state from a hemp grower. A
3.8manufacturer may manufacture or process hemp into an allowable form of medical cannabis
3.9under section 152.22, subdivision 6. Hemp acquired by a manufacturer under this paragraph
3.10is subject to the same quality control program, security and testing requirements, and other
3.11requirements that apply to medical cannabis under sections 152.22 to 152.37 and Minnesota
3.12Rules, chapter 4770.
3.13(c) A medical cannabis manufacturer shall contract with a laboratory approved by the
3.14commissioner, subject to any additional requirements set by the commissioner, for purposes
3.15of testing medical cannabis manufactured or hemp acquired by the medical cannabis
3.16manufacturer as to content, contamination, and consistency to verify the medical cannabis
3.17meets the requirements of section 152.22, subdivision 6. The cost of laboratory testing shall
3.18be paid by the manufacturer.
3.19(d) The operating documents of a manufacturer must include:
3.20(1) procedures for the oversight of the manufacturer and procedures to ensure accurate
3.21record keeping;
3.22(2) procedures for the implementation of appropriate security measures to deter and
3.23prevent the theft of medical cannabis and unauthorized entrance into areas containing medical
3.24cannabis; and
3.25(3) procedures for the delivery and transportation of hemp between hemp growers and
3.26manufacturers.
3.27(e) A manufacturer shall implement security requirements, including requirements for
3.28the delivery and transportation of hemp, protection of each location by a fully operational
3.29security alarm system, facility access controls, perimeter intrusion detection systems, and
3.30a personnel identification system.
3.31(f) A manufacturer shall not share office space with, refer patients to a health care
3.32practitioner, or have any financial relationship with a health care practitioner.
4.1(g) A manufacturer shall not permit any person to consume medical cannabis on the
4.2property of the manufacturer.
4.3(h) A manufacturer is subject to reasonable inspection by the commissioner.
4.4(i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not
4.5subject to the Board of Pharmacy licensure or regulatory requirements under chapter 151.
4.6(j) A medical cannabis manufacturer may not employ any person who is under 21 years
4.7of age or who has been convicted of a disqualifying felony offense. An employee of a
4.8medical cannabis manufacturer must submit a completed criminal history records check
4.9consent form, a full set of classifiable fingerprints, and the required fees for submission to
4.10the Bureau of Criminal Apprehension before an employee may begin working with the
4.11manufacturer. The bureau must conduct a Minnesota criminal history records check and
4.12the superintendent is authorized to exchange the fingerprints with the Federal Bureau of
4.13Investigation to obtain the applicant's national criminal history record information. The
4.14bureau shall return the results of the Minnesota and federal criminal history records checks
4.15to the commissioner.
4.16(k) A manufacturer may not operate in any location, whether for distribution or
4.17cultivation, harvesting, manufacturing, packaging, or processing, within 1,000 feet of a
4.18public or private school existing before the date of the manufacturer's registration with the
4.19commissioner.
4.20(l) A manufacturer shall comply with reasonable restrictions set by the commissioner
4.21relating to signage, marketing, display, and advertising of medical cannabis.
4.22(m) Before a manufacturer acquires hemp from a hemp grower, the manufacturer must
4.23verify that the hemp grower has a valid license issued by the commissioner of agriculture
4.24under chapter 18K.
4.25(n) Until a state-centralized, seed-to-sale system is implemented that can track a specific
4.26medical cannabis plant from cultivation through testing and point of sale, the commissioner
4.27shall conduct at least one unannounced inspection per year of each manufacturer that includes
4.28inspection of:
4.29(1) business operations;
4.30(2) physical locations of the manufacturer's manufacturing facility and distribution
4.31facilities;
4.32(3) financial information and inventory documentation, including laboratory testing
4.33results; and
5.1(4) physical and electronic security alarm systems."
5.2Amend the title accordingly